LU93092I2 - Alemtuzumab - Google Patents

Alemtuzumab Download PDF

Info

Publication number
LU93092I2
LU93092I2 LU93092C LU93092C LU93092I2 LU 93092 I2 LU93092 I2 LU 93092I2 LU 93092 C LU93092 C LU 93092C LU 93092 C LU93092 C LU 93092C LU 93092 I2 LU93092 I2 LU 93092I2
Authority
LU
Luxembourg
Prior art keywords
alemtuzumab
Prior art date
Application number
LU93092C
Other languages
English (en)
Original Assignee
Alcafleu Man Gmbh & Co Kg
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38734000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU93092(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alcafleu Man Gmbh & Co Kg, Genzyme Corp filed Critical Alcafleu Man Gmbh & Co Kg
Publication of LU93092I2 publication Critical patent/LU93092I2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
LU93092C 2006-09-13 2016-05-31 Alemtuzumab LU93092I2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84425106P 2006-09-13 2006-09-13
EP06090169 2006-09-14
EP07802348.8A EP2066352B1 (de) 2006-09-13 2007-09-11 Behandlung von multipler sklerose (ms) mit campath-1h
PCT/EP2007/008084 WO2008031626A1 (en) 2006-09-13 2007-09-11 Treatment of multiple sclerosis (ms) with campath-1h

Publications (1)

Publication Number Publication Date
LU93092I2 true LU93092I2 (de) 2016-08-01

Family

ID=38734000

Family Applications (1)

Application Number Title Priority Date Filing Date
LU93092C LU93092I2 (de) 2006-09-13 2016-05-31 Alemtuzumab

Country Status (21)

Country Link
EP (4) EP2066352B1 (de)
JP (6) JP5872756B2 (de)
KR (2) KR20150039879A (de)
CN (1) CN102652832A (de)
AR (1) AR062779A1 (de)
BR (1) BRPI0716929A8 (de)
CA (1) CA2662531A1 (de)
CY (1) CY2016019I2 (de)
DK (1) DK2066352T3 (de)
ES (2) ES2917882T3 (de)
HR (1) HRP20160211T1 (de)
HU (2) HUE026740T2 (de)
IL (3) IL197236A (de)
LT (1) LTC2066352I2 (de)
LU (1) LU93092I2 (de)
MX (2) MX2009002660A (de)
PL (2) PL3028718T3 (de)
PT (2) PT2066352E (de)
RS (1) RS54658B1 (de)
SI (1) SI2066352T1 (de)
WO (1) WO2008031626A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS54658B1 (sr) 2006-09-13 2016-08-31 Alcafleu Management Gmbh & Co. Kg Lečenje multiple skleroze (ms) sa kampat-1 h
US9498528B2 (en) 2006-09-13 2016-11-22 Genzyme Corporation Treatment of multiple sclerosis (MS)
JP5894912B2 (ja) 2009-05-13 2016-03-30 ジェンザイム・コーポレーション 抗ヒトｃｄ５２免疫グロブリン
AR095199A1 (es) 2013-03-15 2015-09-30 Genzyme Corp Anticuerpos anti-cd52
WO2018195457A2 (en) * 2017-04-21 2018-10-25 Genzyme Corporation Treatment of multiple sclerosis with anti-cd52 antibodies
US20220015500A1 (en) * 2018-12-12 2022-01-20 University Of Delaware Vibrational device and methods for mitigating symptoms of freezing of gait

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846534A (en) 1988-02-12 1998-12-08 British Technology Group Limited Antibodies to the antigen campath-1
GB9125768D0 (en) * 1991-12-04 1992-02-05 Hale Geoffrey Therapeutic method
RS54658B1 (sr) 2006-09-13 2016-08-31 Alcafleu Management Gmbh & Co. Kg Lečenje multiple skleroze (ms) sa kampat-1 h

Also Published As

Publication number Publication date
JP2016175929A (ja) 2016-10-06
RS54658B1 (sr) 2016-08-31
JP2014058555A (ja) 2014-04-03
EP2433649A2 (de) 2012-03-28
AU2007296857A1 (en) 2008-03-20
CY2016019I1 (el) 2016-10-05
EP2066352A1 (de) 2009-06-10
LTPA2016019I1 (lt) 2016-06-27
KR20090063215A (ko) 2009-06-17
HUS1600028I1 (hu) 2016-07-28
PT3028718T (pt) 2022-06-09
AR062779A1 (es) 2008-12-03
JP5872756B2 (ja) 2016-03-01
CA2662531A1 (en) 2008-03-20
EP2066352B1 (de) 2015-12-02
JP2010503631A (ja) 2010-02-04
EP2444104A3 (de) 2012-10-24
JP2019167385A (ja) 2019-10-03
KR101583587B1 (ko) 2016-01-08
HUE026740T2 (en) 2016-07-28
IL240394A0 (en) 2015-09-24
WO2008031626A1 (en) 2008-03-20
ES2917882T3 (es) 2022-07-12
PL2066352T3 (pl) 2016-05-31
RU2009113665A (ru) 2010-10-20
IL197236A0 (en) 2011-08-01
PT2066352E (pt) 2016-03-31
IL197236A (en) 2015-08-31
EP2433649A3 (de) 2012-10-31
MX354080B (es) 2018-02-12
BRPI0716929A8 (pt) 2019-02-05
JP2018024655A (ja) 2018-02-15
HK1136773A1 (en) 2010-07-09
JP2021107423A (ja) 2021-07-29
CN102652832A (zh) 2012-09-05
EP2444104A2 (de) 2012-04-25
EP3028718A1 (de) 2016-06-08
BRPI0716929A2 (pt) 2013-09-17
JP6257287B2 (ja) 2018-01-10
DK2066352T3 (en) 2016-02-29
IL240394B (en) 2018-02-28
IL257341A (en) 2018-03-29
MX2009002660A (es) 2009-06-11
CY2016019I2 (el) 2016-10-05
EP3028718B1 (de) 2022-03-23
KR20150039879A (ko) 2015-04-13
LTC2066352I2 (lt) 2017-09-25
SI2066352T1 (sl) 2016-05-31
PL3028718T3 (pl) 2022-11-21
HRP20160211T1 (hr) 2016-03-25
ES2563068T3 (es) 2016-03-10

Similar Documents

Publication Publication Date Title
DK2096917T3 (da) Cyclopamin-analoger
DK2081937T3 (da) Triazolopyridazin-proteinkinasemodulatorer
DE602006019782D1 (de) Kapselperforationsmodul
DE602007002544D1 (de) Nuancierungsmittel
EP1984575A4 (de) Verschleissanordnung
DE602007008423D1 (de) Flüssigkeitshärtung
DE602007009650D1 (de) Spiroindolinonderivate
DE602007006947D1 (de) Pyridopyrimidinonderivate
AT504580A3 (de) Scan-einrichtung
DE602007000258D1 (de) Kassetteneinspannmechanismus
EP1996173A4 (de) Pulverfüllverfahren
DE602007001280D1 (de) Getränkeextraktor
EP1996823A4 (de) Klammermutter
DE602007010359D1 (de) Azaspiroderivate
DE602007008400D1 (de) Kaliummonopersulfatlösungen
DE502007001629D1 (de) Rfahren
BRPI0717939A2 (pt) Aminometil-4-imidazóis
DE502007000218D1 (de) nsetzungen
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE602007000501D1 (de) Breitbandrichtkoppler
DE602007010544D1 (de) Motorstatorstruktur
DE602007004080D1 (de) Tintenstrahlaufnehmer
DE602007001098D1 (de) Spindelmäheinheit
DE602007007460D1 (de) Sehkrafttestsystem
DE502007000361D1 (de) Stanznieteinheit